6/4/2012 6:44:27 AM
Roche Diagnostics (VX: ROG), a division of Roche Holdings (RHHBY.PK), will spend $310 million in China over the next few years to increase its revenues, adding offices in nine cities across China (see story). The company will also invest in "personnel development, recruitment, instruments and systems," according to Roche Diagnostic's COO, Daniel O'Day. Roche Diagnostics wants China to be its second largest market, up from fifth currently.
comments powered by